Study

EORTC-08092-MAPPING

Double blind randomized phase III study of maintenance Pazopanib versus placebo in NSCLC patients non progressive after first line chemotherapy.

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 18-Jul-2011
Date Step1 close: 05-Aug-2013

Data management at EORTC

Yes

Design

Phase 3
Randomized blind

Protocol summary

http://clinicaltrials.gov/study/NCT01208064

NCT number

NCT01208064

EudraCT

2010-018566-23